SAGE THERAPEUTICS INC shareholders Q3 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NATIXIS 31,000$637,9800.01%
MetLife Investment Management, LLC 27,683$569,7160.01%
Fisher Asset Management, LLC 399,619$8,224,1590.01%
OPPENHEIMER & CO INC 11,305$232,6570.01%
AMERIPRISE FINANCIAL INC 712,424$14,661,6870.01%
STATE STREET CORP 4,378,467$90,108,8510.01%
LMR Partners LLP 15,200$312,8160.00%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 21,020$4330.00%
D. E. Shaw & Co., Inc. 202,202$4,161,3170.00%
FARALLON CAPITAL MANAGEMENT LLC 42,800$880,8240.00%
AMERICAN INTERNATIONAL GROUP, INC. 26,385$543,0030.00%
Leucadia National 24,000$493,9200.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 364,342$7,498,1580.00%
SG Americas Securities, LLC 18,607$3830.00%
Squarepoint Ops LLC 68,925$1,418,4770.00%
JPMORGAN CHASE & CO 1,668,518$34,338,1000.00%
Ameritas Investment Partners, Inc. 5,253$108,1070.00%
METROPOLITAN LIFE INSURANCE CO/NY 3,029$62,3370.00%
Red Tortoise LLC 190$3,9100.00%
NORTHERN TRUST CORP 629,778$12,960,8320.00%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.